Latest 23andMe Stories
Research suggests that complex interactions underlie the development of myopia in humans In the largest ever genome-wide association study on myopia, 23andMe, the leading personal genetics company, identified 20 new genetic associations for myopia, or nearsightedness. The company also replicated two known associations in the study, which was specific to individuals of European ancestry. The study included an analysis of genetic data and survey responses from more than 50,000 23andMe...
-- $53 million matched, positioning Foundation for continued impact; opportunity and need persist in challenged research funding environment -- NEW YORK, Feb. 27, 2013 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that with the help of the Parkinson's community, it has completed and surpassed the $50-million Brin Wojcicki Challenge. Longtime Foundation supporters Sergey Brin and Anne Wojcicki have matched more than $53 million in...
SAN MATEO, Calif., Jan. 18, 2013 /PRNewswire/ -- PPC Associates, which runs digital marketing campaigns for some of Silicon Valley's hottest companies, has added a new wave of clients to its billboard in the heart of Silicon Valley. "PPC Associates had a fantastic 2012, and we are deeply thankful to our amazing clients for helping us become one of the top online marketing agencies in the world," CEO David Rodnitzky said. "We thought a billboard highlighting some of these great...
SAN MATEO, Calif., Jan. 4, 2013 /PRNewswire/ -- PPC Associates, which runs digital marketing campaigns for some of Silicon Valley's hottest companies, has launched a billboard on US. Route 101 North, in the heart of Silicon Valley, to commemorate an unprecedented year of growth. "PPC Associates had a fantastic 2012, and we are deeply thankful to our amazing clients for helping us become one of the top online marketing agencies in the world," CEO David Rodnitzky said. "We thought a...
MOUNTAIN VIEW, Calif., Dec. 20, 2012 /PRNewswire/ -- 23andMe has released its third annual list of the ten most interesting and significant genetic findings in 2012 as part of the company's ongoing efforts to understand the role of genetics in personal health and human development. "It's a very exciting time in the world of genetics. Technology improvements and big datasets are making incredible advancements possible," said Anne Wojcicki, co-founder and CEO of 23andMe. "Our own...
MOUNTAIN VIEW, Calif., Dec. 13, 2012 /PRNewswire/ -- 23andMe, the leading personal genetics company, today announced the availability of Ancestry Composition, a new feature that provides state-of-the-art geographic illustration of an individual's ancestral origins. Using 22 reference populations, the feature indicates what percent of a person's ancestry comes from various regions around the world. The analysis includes DNA inherited from all ancestors on both sides of the family....
MOUNTAIN VIEW, Calif., Dec. 4, 2012 /PRNewswire/ -- 23andMe has received grants totaling $573,000 from the National Institutes of Health (NIH) to support three projects that utilize 23andMe's unique web-based research platform. These include projects to better understand the genetics of allergies; to assess accuracy of new sequencing technologies in clinical applications; and to develop tools that will take advantage of the genotypic and phenotypic information in the 23andMe...
MOUNTAIN VIEW, Calif., Oct. 16, 2012 /PRNewswire/ -- Today 23andMe, the leading personal genetics company, announces the appointment of Christine Castro as Vice President Communications, Neil Rothstein as Vice President Marketing, and Jonathan Ward as Vice President Strategic Alliances joining the company's executive leadership team. As Vice President, Communications, Chris Castro is responsible for the company's corporate communications, media relations and investor relations...
MOUNTAIN VIEW, Calif., Oct. 15, 2012 /PRNewswire/ -- In a new theoretical study, 23andMe, the leading personal genetics company, developed a mathematical model which shows that family history and genetic tests offer different strengths. The study results suggest that both family history and genetics are best used in combination to improve disease risk prediction. The full results of the study have now been published online in the journal PLOS Genetics. Family history is most useful...
Connie K. Ho for redOrbit.com – Your Universe Online 23andMe, a company focused on personal genetics, recently took the first step in working towards Food and Drug Administration (FDA) clearance; the FDA plans to review the paperwork over the next few months. Previously, the Silicon Valley company refrained from government regulation, claiming that the service provided consumers with information rather than a medical service. CBS News reported that 23andMe submitted the first group of...
